Neurocrine Biosciences, Inc. today announced the release of findings from a new survey revealing the significant impact of tardive dyskinesia (TD) on people's ability to work, go to school, volunteer ...

Kate Biberdorf, also known as "Kate the Chemist," describes the small spot on her skin that led to a melanoma diagnosis at ...

Iterion Therapeutics, a clinical-stage biopharmaceutical company developing novel therapies for Wnt/β-catenin-driven cancers, ...